BlueCollar Workers May Be Key Winners in the AI Economy ATT CEO Suggests Supermicro and Verda Launch Sustainable AI Cloud Infrastructure for NextGeneration Workloads Stifel Raises Semtech Price Target to 188 Amid Data Center Demand Optimism Berkshire Hathaways Portfolio Revamp 26 Billion Delta Stake and 224 Alphabet Increase Reddit Stock Slides Nearly 6 After Meta Launches Standalone Forum App EasyJet Assures Summer Flight Schedule Unaffected by Jet Fuel Supply Concerns CRNX Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Management and Pipeline Progress Arch Capital Group Ltd Depositary Shares Series G ACGLN Q1 2026 Earnings Preferred EPS Slightly Misses Estimates Stock Holds Steady NFT Limited MI Q3 2018 Earnings Massive EPS Miss Sends Stock Sharply Lower VG Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain JUNS Q4 2025 Earnings Narrower Loss Surprises Yet Stock Falls on PreRevenue Path Accendra Health Inc ACH Q1 2026 Earnings EPS Beats Estimates with a 609 Surprise as Narrower Loss Fuels Investor Optimism Independent Bank Corp INDB Rises 11 as Regional Bank Sector Holds Steady PVH Corp PVH Bounces 255 From Support Testing NearTerm Resistance DTE Energy Junior Subordinated Debenture DTW Edges Higher in Quiet Trading AngloGold Ashanti AU Slips 145 Gold Miner Hovers Between Key Support and Resistance Beeline Holdings BLNE Surges 1441 Testing Resistance at 142 After Breakout LMP Capital and Income Fund SCD Edges Higher Amid Modest Gains Key Levels in Focus Phoenix New Media FENG Shares Decline Amid Light Trading Testing Key Support Levels Thornburg Income Builder Opportunities Trust TBLD Holds Steady Above Key Support Eyes Resistance Tempest Therapeutics TPST Edges Higher as Biotech Sector Shows Renewed Interest Roadzen Inc Warrants RDZNW Surge Warrants Rally 175 as Support Holds at 023 FMNB Slips Slightly as Traders Eye Key Support and Resistance Levels FRI Dividend Declines 10 Why Income Investors May Not Need to Worry Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline Antelope Enterprise AEHL Tests Support as Downside Momentum Persists